Duke-NUS to co-develop, produce one-of-its-kind Covid-19 test kit with partners

Duke-NUS Medical School has come up with a test kit that takes just an hour, instead of the usual several days, to detect if someone has antibodies which can neutralise the coronavirus that causes Covid-19.

The new test, which The Straits Times first reported on earlier this month, can be used to see if potential vaccines work, to check what proportion of the population has already been infected and for contact tracing, which is critical as Singapore eases up on circuit breaker measures.

Known as cPass, the first-of-its-kind test is available to hospitals here.

When someone is infected with the virus, the body produces hundreds, if not thousands, of different antibodies, which bind with the virus and are known as binding antibodies. However, not all of them can neutralise the virus. This is the role of neutralising antibodies, which bind with proteins on the virus’ shell, preventing it from attaching itself to a person’s cells.
Read the full story from The Straits Times.
Show More

AppliedHE News Wire

This is the official news distribution system of AppliedHE. We strive to bring you the latest higher education, skills development and employment stories from around world. We go direct to the source or we highlight important new developments by relying on a diverse range of trusted and independent media sources.

Related Articles

Back to top button